bionlp-st-ge-2016-spacy-parsed Home  

PMC:3312845 / 23715-24631 JSONTXT 22 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T9618 0-10 RB denotes Previously
T9619 10-11 , denotes ,
T9620 12-14 PRP denotes we
T9621 15-23 VBD denotes reported
T9622 24-28 IN denotes that
T9623 29-35 NNP denotes SMI-71
T9624 36-37 -LRB- denotes (
T9625 37-39 DT denotes an
T9626 40-51 JJ denotes endothelial
T9627 52-59 NN denotes barrier
T9628 60-67 NN denotes antigen
T9629 67-68 -RRB- denotes )
T9630 69-85 NN denotes immunoreactivity
T9631 86-95 VBN denotes decreased
T9632 96-98 IN denotes in
T9633 99-102 DT denotes the
T9634 103-105 NN denotes PC
T9635 106-107 CD denotes 1
T9636 108-111 NN denotes day
T9637 112-117 IN denotes after
T9638 118-120 NNP denotes SE
T9639 121-122 NNP denotes [
T9640 122-123 CD denotes 5
T9641 123-124 NNP denotes ]
T9642 124-125 . denotes .
T9643 126-135 RB denotes Similarly
T9644 135-136 , denotes ,
T9645 137-139 IN denotes in
T9646 140-141 CD denotes 1
T9647 142-150 JJ denotes day-post
T9648 151-153 NNP denotes SE
T9649 154-161 NNS denotes animals
T9650 162-164 IN denotes of
T9651 165-168 DT denotes the
T9652 169-183 JJ denotes saline-infused
T9653 184-189 NN denotes group
T9654 189-190 , denotes ,
T9655 191-195 NN denotes loss
T9656 196-198 IN denotes of
T9657 199-205 NNP denotes SMI-71
T9658 206-222 NN denotes immunoreactivity
T9659 223-226 VBD denotes was
T9660 227-235 VBN denotes detected
T9661 236-238 IN denotes in
T9662 239-244 NN denotes layer
T9663 245-251 NNP denotes III/IV
T9664 252-254 IN denotes of
T9665 255-258 DT denotes the
T9666 259-261 NN denotes PC
T9667 262-264 IN denotes as
T9668 265-273 VBN denotes compared
T9669 274-276 TO denotes to
T9670 277-283 JJ denotes non-SE
T9671 284-291 NNS denotes animals
T9672 292-293 -LRB- denotes (
T9673 293-300 NNS denotes Figures
T9674 301-303 NN denotes 4B
T9675 304-307 CC denotes and
T9676 308-312 JJ denotes 5C-E
T9677 312-313 , denotes ,
T9678 314-315 JJ denotes p
T9679 316-317 NN denotes <
T9680 318-322 CD denotes 0.05
T9681 322-323 -RRB- denotes )
T9682 323-324 . denotes .
T9683 325-329 RB denotes Thus
T9684 329-330 , denotes ,
T9685 331-335 NN denotes loss
T9686 336-338 IN denotes of
T9687 339-345 NNP denotes SMI-71
T9688 346-362 NN denotes immunoreactivity
T9689 363-373 VBN denotes correlated
T9690 374-378 IN denotes with
T9691 379-385 NN denotes volume
T9692 386-388 IN denotes of
T9693 389-398 JJ denotes vasogenic
T9694 399-404 NN denotes edema
T9695 405-414 VBG denotes following
T9696 415-417 NNP denotes SE
T9697 417-418 . denotes .
T9698 419-423 DT denotes This
T9699 424-433 NN denotes reduction
T9700 434-436 IN denotes in
T9701 437-443 NN denotes SMI-71
T9702 444-447 VBD denotes was
T9703 448-459 VBN denotes accompanied
T9704 460-462 IN denotes by
T9705 463-472 VBN denotes increased
T9706 473-483 NN denotes p65-Thr435
T9707 484-499 NN denotes phosphorylation
T9708 500-501 -LRB- denotes (
T9709 501-508 NNS denotes Figures
T9710 509-513 NN denotes 5C-D
T9711 513-514 -RRB- denotes )
T9712 514-515 . denotes .
T9713 516-525 RB denotes Therefore
T9714 525-526 , denotes ,
T9715 527-530 DT denotes the
T9716 531-537 NN denotes degree
T9717 538-540 IN denotes of
T9718 541-547 NNP denotes SMI-71
T9719 548-564 NN denotes immunoreactivity
T9720 565-568 VBD denotes was
T9721 569-578 RB denotes inversely
T9722 579-589 VBN denotes correlated
T9723 590-592 TO denotes to
T9724 593-603 JJ denotes p65-Thr435
T9725 604-619 NN denotes phosphorylation
T9726 620-624 IN denotes with
T9727 625-626 DT denotes a
T9728 627-633 JJ denotes linear
T9729 634-645 NN denotes coefficient
T9730 646-648 IN denotes of
T9731 649-660 NN denotes correlation
T9732 661-663 IN denotes of
T9733 664-671 CD denotes -0.6324
T9734 672-673 -LRB- denotes (
T9735 673-674 NN denotes p
T9736 675-676 NN denotes <
T9737 677-681 CD denotes 0.05
T9738 681-682 : denotes ;
T9739 683-689 NN denotes Figure
T9740 690-692 NN denotes 4C
T9741 692-693 -RRB- denotes )
T9742 693-694 . denotes .
T9743 695-697 IN denotes In
T9744 698-706 NN denotes addition
T9745 706-707 , denotes ,
T9746 708-716 JJ denotes sTNFp55R
T9747 717-725 NN denotes infusion
T9748 726-737 RB denotes effectively
T9749 738-748 VBD denotes alleviated
T9750 749-759 JJ denotes p65-Thr435
T9751 760-775 NN denotes phosphorylation
T9752 776-779 CC denotes and
T9753 780-789 VBD denotes preserved
T9754 790-796 NNP denotes SMI-71
T9755 797-813 NN denotes immunoreactivity
T9756 814-816 IN denotes in
T9757 817-828 JJ denotes endothelial
T9758 829-834 NNS denotes cells
T9759 835-844 VBG denotes following
T9760 845-847 NNP denotes SE
T9761 847-848 , denotes ,
T9762 849-851 IN denotes as
T9763 852-860 VBN denotes compared
T9764 861-863 TO denotes to
T9765 864-870 VB denotes saline
T9766 871-879 NN denotes infusion
T9767 880-881 -LRB- denotes (
T9768 881-882 FW denotes p
T9769 883-884 FW denotes <
T9770 885-889 CD denotes 0.05
T9771 889-890 : denotes ;
T9772 891-898 NNS denotes Figures
T9773 899-903 NN denotes 4A-B
T9774 903-904 , denotes ,
T9775 905-907 NNP denotes 5D
T9776 908-911 CC denotes and
T9777 912-914 NNP denotes 5F
T9778 914-915 -RRB- denotes )
T9779 915-916 . denotes .
R7798 T9618 T9621 advmod Previously,reported
R7799 T9619 T9621 punct ",",reported
R7800 T9620 T9621 nsubj we,reported
R7801 T9621 T9621 ROOT reported,reported
R7802 T9622 T9631 mark that,decreased
R7803 T9623 T9630 nmod SMI-71,immunoreactivity
R7804 T9624 T9623 punct (,SMI-71
R7805 T9625 T9628 det an,antigen
R7806 T9626 T9628 amod endothelial,antigen
R7807 T9627 T9628 compound barrier,antigen
R7808 T9628 T9623 appos antigen,SMI-71
R7809 T9629 T9623 punct ),SMI-71
R7810 T9630 T9631 nsubj immunoreactivity,decreased
R7811 T9631 T9621 ccomp decreased,reported
R7812 T9632 T9631 prep in,decreased
R7813 T9633 T9636 det the,day
R7814 T9634 T9636 nmod PC,day
R7815 T9635 T9636 nummod 1,day
R7816 T9636 T9632 pobj day,in
R7817 T9637 T9636 prep after,day
R7818 T9638 T9641 nmod SE,]
R7819 T9639 T9641 nmod [,]
R7820 T9640 T9641 nummod 5,]
R7821 T9641 T9637 pobj ],after
R7822 T9642 T9621 punct .,reported
R7823 T9643 T9660 advmod Similarly,detected
R7824 T9644 T9660 punct ",",detected
R7825 T9645 T9660 prep in,detected
R7826 T9646 T9649 nummod 1,animals
R7827 T9647 T9649 amod day-post,animals
R7828 T9648 T9649 compound SE,animals
R7829 T9649 T9645 pobj animals,in
R7830 T9650 T9649 prep of,animals
R7831 T9651 T9653 det the,group
R7832 T9652 T9653 amod saline-infused,group
R7833 T9653 T9650 pobj group,of
R7834 T9654 T9653 punct ",",group
R7835 T9655 T9660 nsubjpass loss,detected
R7836 T9656 T9655 prep of,loss
R7837 T9657 T9658 compound SMI-71,immunoreactivity
R7838 T9658 T9656 pobj immunoreactivity,of
R7839 T9659 T9660 auxpass was,detected
R7840 T9660 T9660 ROOT detected,detected
R7841 T9661 T9660 prep in,detected
R7842 T9662 T9663 compound layer,III/IV
R7843 T9663 T9661 pobj III/IV,in
R7844 T9664 T9663 prep of,III/IV
R7845 T9665 T9666 det the,PC
R7846 T9666 T9664 pobj PC,of
R7847 T9667 T9668 mark as,compared
R7848 T9668 T9660 advcl compared,detected
R7849 T9669 T9668 prep to,compared
R7850 T9670 T9671 amod non-SE,animals
R7851 T9671 T9669 pobj animals,to
R7852 T9672 T9674 punct (,4B
R7853 T9673 T9674 compound Figures,4B
R7854 T9674 T9671 appos 4B,animals
R7855 T9675 T9674 cc and,4B
R7856 T9676 T9674 conj 5C-E,4B
R7857 T9677 T9676 punct ",",5C-E
R7858 T9678 T9676 conj p,5C-E
R7859 T9679 T9680 compound <,0.05
R7860 T9680 T9678 nummod 0.05,p
R7861 T9681 T9678 punct ),p
R7862 T9682 T9660 punct .,detected
R7863 T9683 T9689 advmod Thus,correlated
R7864 T9684 T9689 punct ",",correlated
R7865 T9685 T9689 nsubj loss,correlated
R7866 T9686 T9685 prep of,loss
R7867 T9687 T9688 compound SMI-71,immunoreactivity
R7868 T9688 T9686 pobj immunoreactivity,of
R7869 T9689 T9689 ROOT correlated,correlated
R7870 T9690 T9689 prep with,correlated
R7871 T9691 T9690 pobj volume,with
R7872 T9692 T9691 prep of,volume
R7873 T9693 T9694 amod vasogenic,edema
R7874 T9694 T9692 pobj edema,of
R7875 T9695 T9689 prep following,correlated
R7876 T9696 T9695 pobj SE,following
R7877 T9697 T9689 punct .,correlated
R7878 T9698 T9699 det This,reduction
R7879 T9699 T9703 nsubjpass reduction,accompanied
R7880 T9700 T9699 prep in,reduction
R7881 T9701 T9700 pobj SMI-71,in
R7882 T9702 T9703 auxpass was,accompanied
R7883 T9703 T9703 ROOT accompanied,accompanied
R7884 T9704 T9703 agent by,accompanied
R7885 T9705 T9707 amod increased,phosphorylation
R7886 T9706 T9707 compound p65-Thr435,phosphorylation
R7887 T9707 T9704 pobj phosphorylation,by
R7888 T9708 T9710 punct (,5C-D
R7889 T9709 T9710 compound Figures,5C-D
R7890 T9710 T9707 appos 5C-D,phosphorylation
R7891 T9711 T9710 punct ),5C-D
R7892 T9712 T9703 punct .,accompanied
R7893 T9713 T9722 advmod Therefore,correlated
R7894 T9714 T9722 punct ",",correlated
R7895 T9715 T9716 det the,degree
R7896 T9716 T9722 nsubjpass degree,correlated
R7897 T9717 T9716 prep of,degree
R7898 T9718 T9719 compound SMI-71,immunoreactivity
R7899 T9719 T9717 pobj immunoreactivity,of
R7900 T9720 T9722 auxpass was,correlated
R7901 T9721 T9722 advmod inversely,correlated
R7902 T9722 T9722 ROOT correlated,correlated
R7903 T9723 T9722 prep to,correlated
R7904 T9724 T9725 amod p65-Thr435,phosphorylation
R7905 T9725 T9723 pobj phosphorylation,to
R7906 T9726 T9722 prep with,correlated
R7907 T9727 T9729 det a,coefficient
R7908 T9728 T9729 amod linear,coefficient
R7909 T9729 T9726 pobj coefficient,with
R7910 T9730 T9729 prep of,coefficient
R7911 T9731 T9730 pobj correlation,of
R7912 T9732 T9731 prep of,correlation
R7913 T9733 T9732 pobj -0.6324,of
R7914 T9734 T9736 punct (,<
R7915 T9735 T9736 compound p,<
R7916 T9736 T9731 appos <,correlation
R7917 T9737 T9736 nummod 0.05,<
R7918 T9738 T9740 punct ;,4C
R7919 T9739 T9740 compound Figure,4C
R7920 T9740 T9736 appos 4C,<
R7921 T9741 T9740 punct ),4C
R7922 T9742 T9722 punct .,correlated
R7923 T9743 T9749 prep In,alleviated
R7924 T9744 T9743 pobj addition,In
R7925 T9745 T9749 punct ",",alleviated
R7926 T9746 T9747 compound sTNFp55R,infusion
R7927 T9747 T9749 nsubj infusion,alleviated
R7928 T9748 T9749 advmod effectively,alleviated
R7929 T9749 T9749 ROOT alleviated,alleviated
R7930 T9750 T9751 amod p65-Thr435,phosphorylation
R7931 T9751 T9749 dobj phosphorylation,alleviated
R7932 T9752 T9749 cc and,alleviated
R7933 T9753 T9749 conj preserved,alleviated
R7934 T9754 T9755 compound SMI-71,immunoreactivity
R7935 T9755 T9753 dobj immunoreactivity,preserved
R7936 T9756 T9755 prep in,immunoreactivity
R7937 T9757 T9758 amod endothelial,cells
R7938 T9758 T9756 pobj cells,in
R7939 T9759 T9758 acl following,cells
R7940 T9760 T9759 dobj SE,following
R7941 T9761 T9753 punct ",",preserved
R7942 T9762 T9753 prep as,preserved
R7943 T9763 T9762 prep compared,as
R7944 T9764 T9763 prep to,compared
R7945 T9765 T9766 amod saline,infusion
R7946 T9766 T9764 pobj infusion,to
R7947 T9767 T9766 punct (,infusion
R7948 T9768 T9773 advmod p,4A-B
R7949 T9769 T9770 nmod <,0.05
R7950 T9770 T9768 nummod 0.05,p
R7951 T9771 T9768 punct ;,p
R7952 T9772 T9773 compound Figures,4A-B
R7953 T9773 T9766 appos 4A-B,infusion
R7954 T9774 T9773 punct ",",4A-B
R7955 T9775 T9773 conj 5D,4A-B
R7956 T9776 T9775 cc and,5D
R7957 T9777 T9775 conj 5F,5D
R7958 T9778 T9775 punct ),5D
R7959 T9779 T9749 punct .,alleviated